Brief: Taysha Gene Therapies Estimates That Initial Public Offering Price Per Share Will Be Between $18.00 And $20.00
Sept 17 (Reuters) - Taysha Gene Therapies Inc:
* TAYSHA GENE THERAPIES INC - CURRENTLY ESTIMATED THAT
INITIAL
PUBLIC OFFERING PRICE PER SHARE WILL BE BETWEEN $18.00 AND
$20.00
* TAYSHA GENE THERAPIES INC SEES IPO OF 6.6 MILLION SHARES
OF
COMMON STOCK - SEC FILING
Source text: (https://bit.ly/35JsDuR)
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Taysha Gene Therapies
See all newsUniqure jumps after FDA vaccines chief Vinay Prasad to step down
US FDA names agency critic Vinay Prasad as top vaccine official (updated)
Gene therapy and vaccine makers fall after FDA names Vinay Prasad as top vaccine official
Gene therapy and vaccine makers fall after FDA names Vinay Prasad as top vaccine official
US FDA names oncologist Vinay Prasad as top vaccine official (updated)